KVUE Quote, Financials, Valuation and Earnings

Kimberly-Clark Corp. has a net margin of 8.73% compared to Kenvue, Inc.'s net margin of 9.58%. Kenvue, Inc.'s return on equity of 14.18% beat Kimberly-Clark Corp.'s return on equity of 127.51%.

Kenvue, Inc. has a consensus price target of $19.75, signalling upside risk potential of 8.82%. On the other hand Kimberly-Clark Corp. has an analysts' consensus of $119.21 which suggests that it could grow by 13.93%. Given that Kimberly-Clark Corp. has higher upside potential than Kenvue, Inc., analysts believe Kimberly-Clark Corp. is more attractive than Kenvue, Inc..

Kenvue, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kimberly-Clark Corp. has a beta of 0.245, suggesting its less volatile than the S&P 500 by 75.533%.

Kenvue, Inc. has a quarterly dividend of $0.21 per share corresponding to a yield of 4.56%. Kimberly-Clark Corp. offers a yield of 4.82% to investors and pays a quarterly dividend of $1.26 per share. Kenvue, Inc. pays 107.98% of its earnings as a dividend. Kimberly-Clark Corp. pays out 83.09% of its earnings as a dividend. Kimberly-Clark Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Kenvue, Inc.'s is not.

Kenvue, Inc. quarterly revenues are $3.8B, which are smaller than Kimberly-Clark Corp. quarterly revenues of $4.1B. Kenvue, Inc.'s net income of $330M is lower than Kimberly-Clark Corp.'s net income of $391M. Notably, Kenvue, Inc.'s price-to-earnings ratio is 23.76x while Kimberly-Clark Corp.'s PE ratio is 17.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue, Inc. is 2.31x versus 2.02x for Kimberly-Clark Corp.. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health Co. has a net margin of 8.73% compared to Kenvue, Inc.'s net margin of -15.61%. Kenvue, Inc.'s return on equity of 14.18% beat The Beauty Health Co.'s return on equity of -19.76%.

Kenvue, Inc. has a consensus price target of $19.75, signalling upside risk potential of 8.82%. On the other hand The Beauty Health Co. has an analysts' consensus of $2.03 which suggests that it could grow by 87.96%. Given that The Beauty Health Co. has higher upside potential than Kenvue, Inc., analysts believe The Beauty Health Co. is more attractive than Kenvue, Inc..

Kenvue, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Beauty Health Co. has a beta of 1.198, suggesting its more volatile than the S&P 500 by 19.782%.

Kenvue, Inc. has a quarterly dividend of $0.21 per share corresponding to a yield of 4.56%. The Beauty Health Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kenvue, Inc. pays 107.98% of its earnings as a dividend. The Beauty Health Co. pays out -- of its earnings as a dividend.

Kenvue, Inc. quarterly revenues are $3.8B, which are larger than The Beauty Health Co. quarterly revenues of $70.7M. Kenvue, Inc.'s net income of $330M is higher than The Beauty Health Co.'s net income of -$11M. Notably, Kenvue, Inc.'s price-to-earnings ratio is 23.76x while The Beauty Health Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue, Inc. is 2.31x versus 0.46x for The Beauty Health Co.. Usually stocks with elevated PS ratios are considered overvalued.

Solesence, Inc. has a net margin of 8.73% compared to Kenvue, Inc.'s net margin of -7.67%. Kenvue, Inc.'s return on equity of 14.18% beat Solesence, Inc.'s return on equity of 6.62%.

Kenvue, Inc. has a consensus price target of $19.75, signalling upside risk potential of 8.82%. On the other hand Solesence, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Kenvue, Inc. has higher upside potential than Solesence, Inc., analysts believe Kenvue, Inc. is more attractive than Solesence, Inc..

Kenvue, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Solesence, Inc. has a beta of 1.099, suggesting its more volatile than the S&P 500 by 9.887%.

Kenvue, Inc. has a quarterly dividend of $0.21 per share corresponding to a yield of 4.56%. Solesence, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kenvue, Inc. pays 107.98% of its earnings as a dividend. Solesence, Inc. pays out -- of its earnings as a dividend.

Kenvue, Inc. quarterly revenues are $3.8B, which are larger than Solesence, Inc. quarterly revenues of $14.6M. Kenvue, Inc.'s net income of $330M is higher than Solesence, Inc.'s net income of -$1.1M. Notably, Kenvue, Inc.'s price-to-earnings ratio is 23.76x while Solesence, Inc.'s PE ratio is 84.29x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue, Inc. is 2.31x versus 1.36x for Solesence, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Sentient Brands Holdings, Inc. has a net margin of 8.73% compared to Kenvue, Inc.'s net margin of -1.07%. Kenvue, Inc.'s return on equity of 14.18% beat Sentient Brands Holdings, Inc.'s return on equity of --.

Kenvue, Inc. has a consensus price target of $19.75, signalling upside risk potential of 8.82%. On the other hand Sentient Brands Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Kenvue, Inc. has higher upside potential than Sentient Brands Holdings, Inc., analysts believe Kenvue, Inc. is more attractive than Sentient Brands Holdings, Inc..

Kenvue, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sentient Brands Holdings, Inc. has a beta of -0.096, suggesting its less volatile than the S&P 500 by 109.641%.

Kenvue, Inc. has a quarterly dividend of $0.21 per share corresponding to a yield of 4.56%. Sentient Brands Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Kenvue, Inc. pays 107.98% of its earnings as a dividend. Sentient Brands Holdings, Inc. pays out -- of its earnings as a dividend.

Kenvue, Inc. quarterly revenues are $3.8B, which are larger than Sentient Brands Holdings, Inc. quarterly revenues of $373.8K. Kenvue, Inc.'s net income of $330M is higher than Sentient Brands Holdings, Inc.'s net income of -$4K. Notably, Kenvue, Inc.'s price-to-earnings ratio is 23.76x while Sentient Brands Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Kenvue, Inc. is 2.31x versus 3.63x for Sentient Brands Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.